Grail announces layoffs as it looks to push forward blood-based cancer detection test STAT Flying solo, Grail will cut 30% of staff and narrow its R&D, commercial focus Fierce Biotech Grail Shares Rise on Higher 2Q Revenue, Plans to Reduce Workforce MarketWatch Grail Inc: Cancer test maker Grail…
Continue reading...
Continue reading...